Provider P17-20 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program Read More
Provider QP23-20 Blue Cross Basic Seminar Now Available On-Demand through the Availity Portal Read More
Provider QP17-20 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Wakix ® Read More
Provider QP14R1-20 Update: New Service Type Options for Inpatient Admission Notifications on Availity Portal Read More
Provider QP21-20 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Baclofen Read More
Provider QP18-20 Pharmacy Benefit Exclusion for Calcipotriene-Betamethasone Dipropionate Suspension 0.005-0.064% (authorized generic (AG) of Taclonex suspension) Read More
